We are live on ! Find out more
CORT icon

Corcept Therapeutics
CORT

212 hedge funds and large institutions have $1.45B invested in Corcept Therapeutics in 2018 Q1 according to their latest regulatory filings, with 57 funds opening new positions, 66 increasing their positions, 68 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

78% more first-time investments, than exits

New positions opened: 57 | Existing positions closed: 32

12% more funds holding

Funds holding: 190 → 212 (+22)

10% more call options, than puts

Call options by funds: $10.8M | Put options by funds: $9.82M

3% less repeat investments, than reductions

Existing positions increased: 66 | Existing positions reduced: 68

1.33% less ownership

Funds ownership: 77.88% → 76.55% (-1.3%)

10% less capital invested

Capital invested by funds: $1.61B → $1.45B (-$159M)

20% less funds holding in top 10

Funds holding in top 10: 5 → 4 (-1)

Holders
212
Holders Change
+22
Holders Change %
+11.58%
% of All Funds
4.86%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.09%
New
57
Increased
66
Reduced
68
Closed
32
Calls
$10.8M
Puts
$9.82M
Net Calls
+$1.02M
Net Calls Change
-$1.53M

Top Buyers

1
BlackRock
BlackRock
New York
+$27.9M
2
NC
Nexthera Capital
New York
+$19.4M
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$15.4M
4
Deutsche Bank
Deutsche Bank
Germany
+$10.3M
5
Norges Bank
Norges Bank
Norway
+$8.82M

Top Sellers

1
Prudential Financial
Prudential Financial
New Jersey
-$23.4M
2
JIM
Jupiter Investment Management
United Kingdom
-$17.1M
3
BIM
Bogle Investment Management
Massachusetts
-$12.7M
4
TA
Teachers Advisors
New York
-$11.5M
5
Vanguard Group
Vanguard Group
Pennsylvania
-$11.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
D.E. Shaw & Co
101
D.E. Shaw & Co
New York
$969K -$1.17M -62,997 -52%
AIG
102
American International Group
New York
$958K -$271K -14,635 -20%
PCM
103
Prelude Capital Management
New York
$934K +$92.1K +4,968 +10%
UBS Group
104
UBS Group
Switzerland
$906K -$64.9K -3,501 -6%
State Board of Administration of Florida Retirement System
105
State Board of Administration of Florida Retirement System
Florida
$842K +$45.4K +2,450 +5%
MSL
106
Mackay Shields LLC
New York
$811K +$914K +49,300 New
Citigroup
107
Citigroup
New York
$767K -$3.76M -202,837 -81%
TI
108
Trexquant Investment
Connecticut
$719K +$810K +43,688 New
MIM
109
MetLife Investment Management
New Jersey
$715K – – –
OSAM
110
O'Shaughnessy Asset Management
Connecticut
$706K -$247K -13,355 -24%
LSERS
111
Louisiana State Employees Retirement System
Louisiana
$696K +$27.8K +1,500 +4%
RJA
112
Raymond James & Associates
Florida
$681K +$27.9K +1,505 +4%
SCA
113
Secor Capital Advisors
New York
$674K +$759K +40,985 New
EVC
114
Eidelman Virant Capital
Missouri
$658K – – –
EAM
115
Evanson Asset Management
California
$655K – – –
MERSOM
116
Municipal Employees' Retirement System of Michigan
Michigan
$626K +$705K +38,070 New
CT
117
Cambridge Trust
Massachusetts
$589K – – –
WG
118
Winton Group
United Kingdom
$588K +$662K +35,723 New
PP
119
Paloma Partners
Connecticut
$586K +$660K +35,605 New
TRSOTSOK
120
Teachers Retirement System of the State of Kentucky
Kentucky
$563K +$317K +17,134 +100%
Balyasny Asset Management
121
Balyasny Asset Management
Illinois
$547K +$616K +33,263 New
Fifth Third Bancorp
122
Fifth Third Bancorp
Ohio
$546K +$615K +33,211 New
CGH
123
Crossmark Global Holdings
Texas
$531K +$599K +32,310 New
Creative Planning
124
Creative Planning
Kansas
$518K +$80.1K +4,321 +16%
BCM
125
Bridgeway Capital Management
Texas
$510K -$98.2K -5,300 -15%
3 4
5
6 7

CORT Hedge Fund Activity: Q1 2018 in Review

212 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Corcept Therapeutics (CORT) for Q1 2018, worth a combined $1.45B — down 9.9% from $1.61B a quarter earlier.

Buyers outnumbered sellers: 57 funds opened new CORT positions and 32 closed out — a net gain of 25 holders — while 66 added to existing stakes and 68 trimmed.

The largest buyer was BlackRock, adding an estimated $27.9M. The largest seller was Prudential Financial, cutting an estimated $23.4M.

  • 212 institutional investors held Corcept Therapeutics (CORT) as of Q1 2018, up from 190 in Q4 2017.
  • Funds reported $1.45B of Corcept Therapeutics stock for Q1 2018, down 9.9% quarter-over-quarter.
  • 57 funds opened new Corcept Therapeutics positions in Q1 2018 and 32 closed out, a net change of +25 holders.
  • The largest Corcept Therapeutics buyer in Q1 2018 was BlackRock, an estimated $27.9M added.
  • The largest Corcept Therapeutics seller in Q1 2018 was Prudential Financial, an estimated $23.4M sold.

Based on aggregated 13F filings for Q1 2018.